Top 5 Health Care Stocks That Are Preparing To Pump In November
Top 5 Health Care Stocks That Are Preparing To Pump In November
Read More: Fear & Greed Index Remains In 'Fear' Zone; Dow Notches Best Day Since June The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健領域超賣次數最多的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30.
RSI是一種動量指標，它比較了股票在價格上漲的日子裏的強度與價格下跌時的強度。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。當 RSI 低於 30 時，資產通常被視爲超賣。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是該行業主要超賣參與者的最新名單，RSI接近或低於30。
Better Therapeutics Inc (NASDAQ:BTTX)
Better Therapeut （納斯達克股票代碼：BTTX）
- Better Therapeutics recently announced the launch of AspyreRxTM to treat adults with Type 2 diabetes. The company's stock has a 52-week low of $0.14 .
- RSI Value: 27.85
- BTTX Price Action: Shares of Better Therapeutics fell 6.1% to close at $0.15 on Thursday.
- Better Therapeutics最近宣佈推出AspyrerXTM，用於治療成人 2 型糖尿病。該公司的股票有一個 52 周低點爲 0.14 美元 。
- RSI 值： 27.85
- BTTX 價格走勢： 週四，Better Therapeutics的股價下跌6.1％，收於0.15美元。
Heart Test Laboratories Inc (NASDAQ:HSCS)
心臟測試實驗室公司 （納斯達克股票代碼：HSCS）
- On Sept. 18, Heart Test Laboratories entered into an equity distribution agreement with Maxim Group as sales agent. It has a 52-week low of $0.20.
- RSI Value: 26.80
- HSCS Price Action: Shares of Heart Test Laboratories fell 8.2% to close at $0.21 on Thursday.
- 9月18日，心臟測試實驗室與作爲銷售代理的Maxim集團簽訂了股權分配協議。它 創下 52 周低點 0.20 美元的。
- RSI 值： 26.80
- HSCS 價格走勢： 週四，心臟測試實驗室股價下跌8.2％，收於0.21美元。
SINTX Technologies Inc (NASDAQ:SINT)
SINTX 科技公司 （納斯達克股票代碼：SINT）
- SINTX Technologies was awarded Phase II NIH grant of $1,972,826 for silicon nitride-PEEK 3D printed composite spinal implants. The company's stock has a 52-week low of $0.40.
- RSI Value: 28.18
- SINT Price Action: Shares of SINTX Technologies fell 6.9% to close at $0.42 on Thursday.
- SINTX Technologies獲得了美國國立衛生研究院第二階段撥款1,972,826美元，用於購買氮化硅Peek 3D打印的複合脊柱植入物。該公司的股票有效期爲52周 低點爲0.40美元。
- RSI 值： 28.18
- SINT 價格走勢： 週四，SINTX Technologies的股價下跌6.9％，收於0.42美元。
Evelo Biosciences Inc (NASDAQ:EVLO)
伊維洛生物科學公司 （納斯達克股票代碼：EVLO）
- Evelo Biosciences reported the primary endpoint in its Phase 2 clinical study with EDP2939 in moderate psoriasis was not achieved. The company also initiated a process to explore strategic alternatives. The company's 52-week low is $0.30.
- RSI Value: 15.98
- EVLO Price Action: Shares of Evelo Biosciences fell 19.4% to close at $0.31 on Thursday.
- Evelo Biosciences報告稱，其針對中度牛皮癬的 EDP2939 2期臨床研究的主要終點未達到。該公司還啓動了探索戰略替代方案的進程。該公司的52周低點爲0.30美元。
- RSI 值： 15.98
- EVLO 價格走勢： 週四，Evelo Biosciences的股價下跌19.4％，收於0.31美元。
Arcutis Biotherapeutics Inc (NASDAQ:ARQT)
Arcutis 生物療法公司 （納斯達克股票代碼：ARQT）
- Arcutis Biotherapeutics announced the pricing of a $100 million public offering of 32.5 million common shares at $2.50 per share. The company has a 52-week low of $2.13.
- RSI Value: 21.70
- ARQT Price Action: Shares of Arcutis Biotherapeutics fell 1.8% to close at $2.22 on Thursday.
- Arcutis Biotherapeutics宣佈公開發行3,250萬股普通股的1億美元，定價爲每股2.50美元。該公司 創下 52 周低點 2.13 美元。
- RSI 值： 21.70
- ARQT 價格走勢： 週四，Arcutis Biotherapeutics的股價下跌1.8％，收於2.22美元。
Read More: Fear & Greed Index Remains In 'Fear' Zone; Dow Notches Best Day Since June
閱讀更多： 恐懼與貪婪指數仍處於 “恐懼” 區域；道瓊斯指數創下6月以來的最佳日子
